| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Director Stock Option (right to buy) | 155.4k | $7.43 | $1.2M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Director Stock Option (right to buy) | 155.4k | $7.43 | $1.2M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Purchase | Common Stock | 50k | $18.00 | $900k | | 05/09/2023 |
| 05/26/2022 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 40k | $0.50 | $20k | | 05/26/2022 |
| 05/16/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 84k | $155.00 | $13M | | 05/16/2022 |
| 05/16/2022 | AbbVie Inc. | ABBV | Exercise | | 84k | $54.86 | $4.6M | | 05/16/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 15.7k | $146.81 | $2.3M | In trust | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 5.2k | $147.60 | $762.7k | In trust | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 4k | $148.71 | $594.8k | In trust | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 100 | $149.38 | $14.9k | In trust | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 15.7k | $146.81 | $2.3M | | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 5.2k | $147.60 | $762.7k | | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 4k | $148.71 | $594.8k | | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 100 | $149.38 | $14.9k | | 03/01/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 5.6k | $147.54 | $825.6k | | 02/25/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 8.3k | $148.62 | $1.2M | | 02/25/2022 |
| 03/01/2022 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 1.1k | $149.14 | $164.2k | | 02/25/2022 |
| 02/25/2022 | AbbVie Inc. | ABBV | Payment of Exercise | Common Stock, $0.01 par value | 30.2k | $149.54 | $4.5M | | 02/25/2022 |
| 02/17/2022 | AbbVie Inc. | ABBV | Grant | | 30.6k | $144.54 | $4.4M | | 02/17/2022 |
| 02/17/2022 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 36.7k | $0.00 | $0 | | 02/17/2022 |
| 02/17/2022 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 8k | $0.00 | $0 | | 02/17/2022 |
| 02/17/2022 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 14.7k | $0.00 | $0 | | 02/17/2022 |
| 02/17/2022 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 8.7k | $0.00 | $0 | | 02/17/2022 |
| 09/07/2021 | AbbVie Inc. | ABBV | Gift | Common Stock, $0.01 par value | 30k | $0.00 | $0 | | 09/07/2021 |
| 09/07/2021 | AbbVie Inc. | ABBV | Gift | Common Stock, $0.01 par value | 30k | $0.00 | $0 | In trust | 09/07/2021 |
| 05/27/2021 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 40k | $2.59 | $103.6k | | 05/27/2021 |
| 02/28/2021 | AbbVie Inc. | ABBV | Payment of Exercise | Common Stock, $0.01 par value | 22.8k | $107.74 | $2.5M | | 02/28/2021 |
| 02/18/2021 | AbbVie Inc. | ABBV | Grant | | 49.1k | $105.92 | $5.2M | | 02/18/2021 |
| 02/18/2021 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 22.3k | $0.00 | $0 | | 02/18/2021 |
| 02/18/2021 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 6.6k | $0.00 | $0 | | 02/18/2021 |
| 02/18/2021 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 8k | $0.00 | $0 | | 02/18/2021 |
| 02/18/2021 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 14.7k | $0.00 | $0 | | 02/18/2021 |
| 12/31/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 5.3k | $3.46 | $18.5k | | 12/31/2020 |
| 11/20/2020 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par share | 6.9k | $98.83 | $681.9k | | 11/20/2020 |
| 11/20/2020 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par shar | 33.1k | $99.49 | $3.3M | | 11/20/2020 |
|